generated by a decrease in resting Na+ and K+ conductance.
tached to the multibarrelied assembly was first driven into the gray matter of the cord. After a stable penetration, the prealigned single electrode was lowered into the same region. With cells that were less than 1.5 mm below the (lateral) cord surface, penetration of the same cell was usually achieved by the second electrode. 14. A preliminary report of these findings has been given in I. Engberg and K. C. Marshall, J. Gen. Physiol. 61, 261 (1973) . 15. The NA was passed by using a positive current, from a 0.5M solution, pH 5 . Current controls were either in the form of balancing opposite currents from another electrode of the assembly or of comparing NA effects with responses to equivalent or higher sodium currents passed from another electrode. Intracellular electrodes were usually filled with KCI, sometimes with citrate.
16. P. E. Voorhoeve, Acta Physiol. Pharmacol. Neerl. 9, 1(1960) . 17. Electrical coupling between the screened intracellular current-passing and recording electrodes was often so small that it could be neglected. In other cases, the coupling was measurable by oscilloscopic examination of the rising and falling phases of short current pulses. The amplitude of the coupling was a linear function of the current amplitude, and was easily corrected by subtracting the appropriate value from the apparent potential displacement resulting from a given current pulse. (6) , but fail to precipitate EMB when injected intracerebrally in naloxone-treated or -naive animals (7).
These findings demonstrate that the ability of opioids to produce physical dependence is not conditional upon their ability to elicit behavioral excitation (that is, EMB).
We question the use of the label "ACTH receptor" to describe the site at which ACTH and opiates are producing EMB. Wei et al. (8) reported that intracerebral injections of thyrotrophin-releasing hormone in rats induce opiate withdrawal-like, wet-dog shakes. We observed (9) EMB after intraventricular injections of either lithium or various calcium chelators, the latter at molar doses below those effective in morphine EMB. Given that the class of substances capable of producing EMB may be fairly large, the designation ACTH receptor may be misleading. In fact, there is evidence that ACTH may act at the endorphin receptor. Some aspects of ACTHinduced behavioral excitation are modified by naloxone (10) . ACTH has affinity for opiate receptors in vitro and it antagonizes morphine analgesia in animals (11) . Thus, the excitatory effects of ACTH may not be independent of its action at the stereospecific endorphin receptor. While we agree that the mechanism subserving EMB may play a role in SCIENCE, VOL. 205, 27 2) Some in vitro (3) and in vivo (4, 5) effects of ACTH that appear to be at variance with the view of a receptor other than the endorphin receptor that mediates some of morphine's actions.
I deal here with these points in this sequence. 1) To date, there is only one report (2) on the dependence liability of /8-endorphin after direct, chronic administration to brain. (The direct route to brain is necessary since it is not yet established that this peptide can cross the blood-brain barrier as an intact peptide.) In this investigation, it is not clear whether the infused peptide was actually the intact, or an altered form of /3-endorphin since the subcutaneously implanted osmotic minipump, maintained at body temperature, served as the reservoir for /3-endorphin over the 70-hour infusion period. Moreover, considering the large size of the intracerebral canntila (outer diameter, 0.81 mm), it is probable that the site of infusion may have overlapped with the aqueduct or fourth ventricle, thereby allowing the injected peptide to diffuse to other central nervous system (CNS) sites through the ventricular fluid. These possible sources of error may explain why abstinence signs (abnormal posture, ear blanching, licking, and ptosis) occurred during the period of infusion, although the authors attribute the reason to be the short interval between surgery and experimentation (which may have been another source of error).
The argument concerning the occurrence or nonoccurrence of EMB following the ICV injection of various compounds fails to make ati important distinction between ICV and PAG injections. The former is nonspecific with respect to site, and therefore mechanism of action (that is, the CNS site or sites which mediate the behavioral effects remain unidentified and can be any site adjacent to the ventricles), while the latter is specific, and more to the point, specific to the site where morphine exerts its effects of analgesia-catatonia and EMB. I have previously reported (6) that PAG injections of some opiates (methadone, levorphanol, etorphine) failed to result in EMB, and only high doses of these agents were able to achieve a mild degree of analgesia. This was seen as due to the high lipophilicity of these opiates which allowed rapid diffusion throughout the CNS. This diffusion, at the same time, activated those CNS sites which exerted an inhibitory influence on the excitatory action of the opiate at the ACTH receptor. In this way, some opiates with high dependence liability fail to cause EMB when injected into the PAG, while the low lipophilicity of morphine allows local effects at the PAG to be expressed.
2) That ACTH(1-24) at 10-6M competitively displaced [3H]dihydromorphine from binding sites in brain (3) is not incompatible with the view that morphine effects are mediated by two receptors, a stereospecific endorphin receptor, and a nonstereospecific ACTH receptor. Moreover, since ACTH has opposite effects from endorphin, it is not surprising that ACTH can antagonize morphine analgesia (mediated by the endorphin receptor) (4).
Excessive grooming induced by ICV injection of ACTH (5) may have been due to a degradation product of ACTH, since this peptide is known to undergo rapid degradation in brain. Naloxone antagonism of this effect may have been mediated by a nonopiate mechanism, since naloxone has been reported to atitagonize the effects of nitrous oxide, yaminobutyric acid, acetylcholine, and so on.
In view of the finding (8) that both /3-endorphin and ACTH are derived from the same "31 k" precursor, it is not unreasonable to assume that these two peptides have correlated functions in the regulation of behavior. 
